- Home
- BGLC vs IMCC Comparison
BGLC vs IMCC Comparison
Compare BGLC & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- IMCC
- Stock Information
- Founded
- BGLC 2017
- IMCC 1980
- Country
- BGLC Malaysia
- IMCC Israel
- Employees
- BGLC N/A
- IMCC N/A
- Industry
- BGLC Medical Specialities
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- BGLC Health Care
- IMCC Health Care
- Exchange
- BGLC Nasdaq
- IMCC Nasdaq
- Market Cap
- BGLC 7.6M
- IMCC 5.0M
- IPO Year
- BGLC N/A
- IMCC N/A
- Fundamental
- Price
- BGLC $0.37
- IMCC $2.11
- Analyst Decision
- BGLC
- IMCC
- Analyst Count
- BGLC 0
- IMCC 0
- Target Price
- BGLC N/A
- IMCC N/A
- AVG Volume (30 Days)
- BGLC 117.9K
- IMCC 11.9K
- Earning Date
- BGLC 11-20-2024
- IMCC 11-11-2024
- Dividend Yield
- BGLC N/A
- IMCC N/A
- EPS Growth
- BGLC N/A
- IMCC N/A
- EPS
- BGLC N/A
- IMCC N/A
- Revenue
- BGLC $9,183,168.00
- IMCC $36,445,402.00
- Revenue This Year
- BGLC N/A
- IMCC $22.59
- Revenue Next Year
- BGLC N/A
- IMCC $20.53
- P/E Ratio
- BGLC N/A
- IMCC N/A
- Revenue Growth
- BGLC N/A
- IMCC N/A
- 52 Week Low
- BGLC $0.31
- IMCC $1.13
- 52 Week High
- BGLC $3.39
- IMCC $8.10
- Technical
- Relative Strength Index (RSI)
- BGLC 32.80
- IMCC 41.06
- Support Level
- BGLC $0.38
- IMCC $2.02
- Resistance Level
- BGLC $0.49
- IMCC $2.15
- Average True Range (ATR)
- BGLC 0.02
- IMCC 0.14
- MACD
- BGLC -0.01
- IMCC -0.01
- Stochastic Oscillator
- BGLC 5.94
- IMCC 19.15
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.